Incanthera (AQSE:INC) OCF Margin %: -5,216.67% (As of Sep. 2025)


What is Incanthera OCF Margin %?

Incanthera AQSE:INC OCF Margin % is -5,216.67% as of Sep. 2025. The stock has 2 warning signs investors should review. Among 957 Biotechnology companies, Incanthera ranks worse than 95.72% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Incanthera's Cash Flow from Operations for the six months ended in Sep. 2025 was £-0.31 Mil. Incanthera's Revenue for the six months ended in Sep. 2025 was £0.01 Mil. Therefore, Incanthera's OCF Margin % for the quarter that ended in Sep. 2025 was -5,216.67%.

As of today, Incanthera's current OCF Yield % is -54.69%.

The historical rank and industry rank for Incanthera's OCF Margin % or its related term are showing as below:

AQSE:INC' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -22633.33

AQSE:INC's OCF Margin % is ranked worse than
95.72% of 957 companies
in the Biotechnology industry
Industry Median: -66.52 vs AQSE:INC: -22633.33

Incanthera OCF Margin % Related Terms

Incanthera OCF Margin % Historical Data

* Premium members only.

The historical data trend for Incanthera's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Incanthera OCF Margin % Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -5,216.67

AQSE:INC vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Incanthera's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incanthera OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Incanthera's OCF Margin % falls into.


Incanthera OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Incanthera's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-3.095/0
= %

Incanthera's OCF Margin for the quarter that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.313/0.006
=-5,216.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -5,216.67% mean?
Incanthera (AQSE:INC) has a OCF Margin % of -5,216.67% as of Sep. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Incanthera and its competitors. According to the industry distribution chart, Incanthera ranks #916 out of 957 companies in the Biotechnology industry, placing it in the top 95.7%.
Is Incanthera's OCF Margin % too high?
Incanthera's current OCF Margin % is -5,216.67%. Based on the distribution chart, Incanthera ranks #916 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Incanthera's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Incanthera ranks #916 out of 957 companies for OCF Margin %. This places Incanthera in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Incanthera and its competitors. Incanthera's current OCF Margin % is -5,216.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Incanthera stock overvalued right now?
Incanthera (AQSE:INC) has a current OCF Margin % of -5,216.67%. The current OCF Margin % is -5,216.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Incanthera (AQSE:INC), the current OCF Margin % is -5,216.67% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Incanthera Business Description

Address C/o Gateley Plc, 98 King Street, Manchester, GBR, M2 4WU
Incanthera PLC is clinical stage drug development. It specializes in dermatology and oncology therapeutics. The company has launched a skincare range called Skin + CELL, which addresses and enhances life quality through effective delivery of bioactive ingredients capable of energising the skin's natural repair and defence processes at the cellular level. It has one reportable segment, namely the development of dermatology and pharmaceutical products, within the United Kingdom and Switzerland.